MiRNA224 Regulation Role on RKIP Gene Expression and Methylation of miRNA224 Gene Promoter Region inEsophageal Squamous Cell Carcinoma
Abstract
To study the expression levels of tumor suppressor gene RIKP and miRNA224 in esophageal squamous cell carcinoma (ESCC) tissues. To determine whether miRNA224 targets RKIP and the methylation status of miRNA224 gene promoter region in esophageal carcinoma. Methods The expression levels of RKIP and miRNA224 in ESCC and normal tissue were detected by using immunohistochemistry and real-time qPCR, respectively. Luciferase assay was used to determine the targeting of miRNA224 to RKIP. The methylation status of miRNA224 promoter region was studied by bisulfite sequencing PCR (BSP). Results In 40 cases of ESCC, RKIP expression was significantly lower than that of normal tissue; miRNA224 expression was higher in ESCC than in paracancerous tissue. Luciferase assay showed that miRNA224 targets RKIP 3′UTR thus inhibit its expression. The miRNA224 gene promoter region was hypomethylated in ESCC. Conclusion Compared with normal tissue, in ESCC, RKIP was downregulated, while miRNA224 was upregulated, and the promoter region of miRNA224 gene was hypomethylated. RKIP is the target of miRNA224, which may be closely related to esophageal squamous cell carcinoma.
Keywords: miRNA224, RKIP, Esophageal squamous cell carcinoma, Methylation
Full Text:
PDFReferences
ACUNZOM, ROMANO G, PALMIERI D, et al. Cross¬talk between MET and EGFR in non-small cell lung cancer involves miR-27a and Sprouty2. Proc Natl AcadSci USA, 2013,110(21):8573-8578.
WUCY. WANG C, GUAN XC, et al. Diagnostic and prognostic implications of a serum mirna panel in oesophageal squamous cell carcinoma. PLoS One, 2014 (9): e92292 2014-03-20 . http;//www. ncbi. nlm. nih. gov/pmc/articles/ РМС3961321/. doi: 10. 1371/journal, pone. 0092292.
ANDREOLI SC, GASPARINI NJ, CARVALHO GP, et al. Use of microRNAs in directing therapy and evaluating treatment response in colorectal cancer. Einstein ( Sao Paulo),2014,12(2):256-258.
ARROYO JD. GALLICHOTTE EN, ТЕ WAR I M. Systematic design and functional analysis of artificial microRNAs. Nucleic Acids Res,2014,42(9);6064-6077. ASSOU S, AL-EDANI T, HAOUZI D, elal. MicroRNAs; new candidates for the regulation of the human cumulus- oocyte complex. Hum Reprod,2013 ,28(11) :3038-3049.
A L-MULL A F, BITAR MS, AL-MAGHREBI M, et al. Raf kinase inhibitor protein rkip enhances signaling by glycogen synthase kinase-3. Cancer Res, 2011, 71 (4 ); 1334- 1343.
BANIN HIRATA BK, ODA JM, LOSI GR, et al. Molecular markers for breast cancer; prediction on tumor behavior. Dis Markers, 2014; 513158[2014-01-28]. http;//www.ncbi.nlm.nih. gov/pmc/articles/PMC3925609/. doi: 10.1155/2014/513158.
VENKATESH T, NAGASHRI MN, SWAMY SS, et al. Primary microcephaly gene mcphl shows signatures of tumor suppressors and is regulated by mir-27a in oral squamous cell carcinoma. PLoS One, 2013, 8 ( 3 ); e54643 [ 2013-03-05]. http :// www. ncbi. nlm. nib. gov/pmc/articles/ РМС3589425/. doi: 10. 1371/journal, pone. 0054643.
HE L. THOMSON JM, HEMANN MT,et al. A microRNA polycistron as a potential human oncogene. Nature, 2005» 435(7043):828-833.
CHENQ. XU J, LI L, et al. MicroRNA-23a/b and microRNA-27a/b suppress Apaf-1 protein and alleviate hypoxia-induced neuronal apoptosis. Cell Death Dis, 2014, 20(5) :el 132[2014-03-20]. http://www. ncbi. nlm. nib. gov/ pmc/articles/PMC3973202/. doi; 10. 1038/cddis. 2014. 92. CHEN Z, CHENG Q, MA Z, etal. Overexpression of rkip inhibits cell invasion in glioma cell lines through upregulation of miR-98. Biomed Res Int, 2013: 695179 [2013-12-12]. http;//www. ncbi. nlm. nib. gov/pmc/articles/ РМС3874320/. doi: 10.1155/2013/695179.
CHEN Z, SAAD R, JIA P. et al. Gastric adenocarcinoma has a unique microRNA signature not present in esophageal adenocarcinoma. Cancer,2013,119(11); 1985-1993.
LIU H. LI P. LI B. et al. RKIP suppresses gastric cancer cell proliferation and invasion and enhances apoptosis regulated by microRNA-224. Tumour Biol, 2014, 35 ( 10 ): 10095-10103.
HUANG L. DAI T, LIN X, et al. MicroRNA-224 targets RKIP to control cell invasion and expression of metastasis genes in human breast cancer cells. Biochem Biophys Res Commun,2012,425(2); 127-133.
BEN JEM A A A, BOURAOUI Y, SALLAMI S, et al. A comparison of the biological features of prostate cancer with (PSA-f, PSMA+) profile according to RKIP. Biomed Res Int,2013:409179_2013-08-07]. http://www. ncbi. nlm. nib. gov/pmc/articles/PMC3749534/. doi; 10.1153/2013/409179.
BIRNER P, JESCH B, SCHULTHEIS A, et al. RAF- kinase inhibitor protein (RKIP) downregulation in esophageal cancer and its metastases. Clin Exp Metastasis,2012,29(6): 551-559.
CALURA Et MARTINI P, SALES G, et al. Wiring miRNAs to pathways: a topological approach to integrate miRNA and mRNA expression profiles. Nucleic Acids Res, 2014 ,42(11) ;e96[2014-05-06], http;//www. ncbi. nlm. nih. gov/pmc/articles/PMC4066781/. doi;10. 1093/nar/gku354.2013,33(4) :378-381.
VANDAMME D, HERRERO A, AL-MULLA F, et al. Regulation of the МАРК pathway by raf kinase inhibitory protein. Crit Rev Oncog,2014 ,19(6) :405-415.
YU M, WANG Q, DING JW, et al. Association between raf kinase inhibitor protein loss and prognosis in cancers of the digestive system: a meta-analysis. Cancer Biomark,2014 , 14(5);389-400.
Refbacks
- There are currently no refbacks.
